re follicular fluid (FF) sphingosine-1-phosphate (S1P) levels in patients at risk of developing ovarian hyperstimulation syndrome (OHSS) altered and in part responsible for the high vascular permeability observed in these patients.Fil: Scotti, Leopoldina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Di Pietro, Mariana. Ministerio de Ciencia. Tecnología e Innovación Productiva. Agencia Nacional de Promoción Cientifíca y Tecnológica; ArgentinaFil: Pascuali, Natalia Marisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicin...
ObjectiveTo investigate the antiapoptosis effect of sphingosine-1-phosphate (S1P) on human fetal ova...
The relationship between human chorionic gonadotropin and ovarian hyperstimulation syndrome (OHSS) i...
Polycystic ovary syndrome (PCOS) is the most common endocrinological pathology among women of reprod...
Can the bioactive lipid sphingosine-1 phosphate (S1P) act as an endothelial barrier-enhancing molecu...
Is ceramide-1-phosphate (C1P) an ovarian protective agent during alkylating chemotherapy?Local admin...
Ovarian transplantation is one of the key approaches to restoring fertility in women who became meno...
Although advances in the prediction and management of OHSS have been introduced, complete prevention...
Ovarian hyperstimulation syndrome (OHSS) is a disorder associated with ovarian stimulation. OHSS fea...
Can Sphingosine-1-phosphate (S1P), a ceramide-induced death pathway inhibitor, prevent cyclophospham...
Chemotherapy damages the reproductive system by enhancing apoptosis, and evidence suggests that targ...
Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid, noteworthy for its involvement both in th...
Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation with gonadotrophin...
Objective: To investigates the effect of sphingosine-1-phosphate (SIP) supplementation on follicular...
Since the regression of the corpus luteum (CL) occurs via a tightly controlled apoptotic process, st...
Este estudo descreve o efeito da esfingosina 1-fosfato (S1P) no desenvolvimento de folículos pré-ant...
ObjectiveTo investigate the antiapoptosis effect of sphingosine-1-phosphate (S1P) on human fetal ova...
The relationship between human chorionic gonadotropin and ovarian hyperstimulation syndrome (OHSS) i...
Polycystic ovary syndrome (PCOS) is the most common endocrinological pathology among women of reprod...
Can the bioactive lipid sphingosine-1 phosphate (S1P) act as an endothelial barrier-enhancing molecu...
Is ceramide-1-phosphate (C1P) an ovarian protective agent during alkylating chemotherapy?Local admin...
Ovarian transplantation is one of the key approaches to restoring fertility in women who became meno...
Although advances in the prediction and management of OHSS have been introduced, complete prevention...
Ovarian hyperstimulation syndrome (OHSS) is a disorder associated with ovarian stimulation. OHSS fea...
Can Sphingosine-1-phosphate (S1P), a ceramide-induced death pathway inhibitor, prevent cyclophospham...
Chemotherapy damages the reproductive system by enhancing apoptosis, and evidence suggests that targ...
Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid, noteworthy for its involvement both in th...
Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation with gonadotrophin...
Objective: To investigates the effect of sphingosine-1-phosphate (SIP) supplementation on follicular...
Since the regression of the corpus luteum (CL) occurs via a tightly controlled apoptotic process, st...
Este estudo descreve o efeito da esfingosina 1-fosfato (S1P) no desenvolvimento de folículos pré-ant...
ObjectiveTo investigate the antiapoptosis effect of sphingosine-1-phosphate (S1P) on human fetal ova...
The relationship between human chorionic gonadotropin and ovarian hyperstimulation syndrome (OHSS) i...
Polycystic ovary syndrome (PCOS) is the most common endocrinological pathology among women of reprod...